Acquired hemophilia A: an underdiagnosed, severe bleeding disorder.
نویسندگان
چکیده
Acquired hemophilia is a rare bleeding disorder caused by autoantibodies that inhibit coagulation factor VIII. In most cases, it manifests with severe, often life‑threatening bleeds. Acquired hemophilia may be idiopathic or secondary to another condition, most commonly other autoimmune disease or cancer. Treatment is directed to stop bleeding and eradicate inhibitory autoantibodies. Like in most life‑threatening conditions, early diagnosis and treatment are essential for good prognosis. Prompt diagnosis and treatment of acquired hemophilia are constantly improving owing to the increasing availability of laboratory diagnostic tests and growing awareness of physicians of various specialties.
منابع مشابه
Successful Perioperative Management of Severe Bleeding From Undiagnosed Acquired Factor VIII Inhibitors.
Introduction: Acquired factor VIII (FVIII) inhibitors, also known as acquired hemophilia A, are rare with an annual incidence of 1-4 per million people [1,2]. Although the majority of cases of acquired FVIII inhibitors are idiopathic, this disorder is associated with underlying malignancies, autoimmune disease, pregnancy, infections, and medications. Bleeding complications are reported in over ...
متن کاملAcquired Hemophilia Successfully Treated With Oral Immunosuppressive Therapy
Acquired hemophilia is a rare disorder associated with serious bleeding in nonhemophilic patients. We had a 40-year-old woman who was diagnosed as acquired hemophilia with a factor VIII inhibitor level of 27.5 BU/mL. She was presented with gross hematuria and severe right shoulder pain, and was successfully treated with daily oral cyclophosphamide and prednisone for 2 weeks. After the remission...
متن کاملAcquired Factor VIII Inhibitors: Three Cases
UNLABELLED Acquired hemophilia A is a rare, but devastating bleeding disorder caused by spontaneous development of autoantibodies directed against coagulation factor VIII. In 40%-50% of patients it is associated with such conditions as the postpartum period, malignancy, use of medications, and autoimmune diseases; however, its cause is unknown in most cases. Acquired hemophilia A should be susp...
متن کاملAcquired Hemophilia: An Overview on Diagnosis and Treatment
Acquired hemophilia (AH) is a rare but severe bleeding diathesis characterized by autoantibodies against a clotting factor, in most cases Factor VIII (FVIII). This bleeding disorder occurs more frequently in the elderly and may be associated with several conditions, such as malignancies, autoimmune diseases, postpartum or drugs; however, about half of cases remain idiopathic. At variance with c...
متن کاملEvaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study)
Background: Recombinant activated factor VII induces hemostasis in patients with coagulopathy disorders. AryoSeven™ as a safe Iranian Recombinant activated factor VII has been available on our market. This study was performed to establish the safety of AryoSeven on patients with coagulopathy disorder. Methods: This single-center, descriptive,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Polskie Archiwum Medycyny Wewnetrznej
دوره 124 4 شماره
صفحات -
تاریخ انتشار 2014